Esperion Therapeutics Inc (ESPR)
1.835
-0.08
(-4.18%)
USD |
NASDAQ |
Apr 17, 16:00
1.835
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Total Assets (Quarterly): 205.80M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 205.80M |
| September 30, 2023 | 221.30M |
| June 30, 2023 | 234.63M |
| March 31, 2023 | 251.82M |
| December 31, 2022 | 247.94M |
| September 30, 2022 | 312.83M |
| June 30, 2022 | 303.98M |
| March 31, 2022 | 342.85M |
| December 31, 2021 | 381.59M |
| September 30, 2021 | 225.26M |
| June 30, 2021 | 280.46M |
| March 31, 2021 | 278.61M |
| December 31, 2020 | 353.26M |
| September 30, 2020 | 250.97M |
| June 30, 2020 | 330.35M |
| March 31, 2020 | 179.64M |
| December 31, 2019 | 214.45M |
| September 30, 2019 | 255.27M |
| June 30, 2019 | 308.81M |
| March 31, 2019 | 236.48M |
| December 31, 2018 | 143.45M |
| September 30, 2018 | 174.03M |
| June 30, 2018 | 210.88M |
| Date | Value |
|---|---|
| March 31, 2018 | 244.19M |
| December 31, 2017 | 277.84M |
| September 30, 2017 | 313.09M |
| June 30, 2017 | 185.24M |
| March 31, 2017 | 214.61M |
| December 31, 2016 | 245.21M |
| September 30, 2016 | 263.79M |
| June 30, 2016 | 277.47M |
| March 31, 2016 | 286.04M |
| December 31, 2015 | 295.57M |
| September 30, 2015 | 306.39M |
| June 30, 2015 | 315.96M |
| March 31, 2015 | 325.22M |
| December 31, 2014 | 143.28M |
| September 30, 2014 | 60.53M |
| June 30, 2014 | 69.29M |
| March 31, 2014 | 70.22M |
| December 31, 2013 | 78.29M |
| September 30, 2013 | 86.58M |
| June 30, 2013 | 19.53M |
| March 31, 2013 | 22.27M |
| December 31, 2012 | 7.312M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
179.64M
Minimum
Mar 2020
381.59M
Maximum
Dec 2021
272.62M
Average
255.27M
Median
Sep 2019
Total Assets (Quarterly) Benchmarks
| United Therapeutics Corp | 7.167B |
| Masimo Corp | 3.042B |
| Heron Therapeutics Inc | 222.51M |
| Aldeyra Therapeutics Inc | 148.33M |
| Aravive Inc (DELISTED) | 13.05M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 660.79M |
| Shareholders Equity (Quarterly) | -454.99M |
| Debt to Equity Ratio | -0.5749 |
| Current Ratio | 1.287 |
| Net Debt Paydown Yield | -0.12% |